Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the β4-integrin gene in human keratinocytes

Journal of Virology

Volumn 84, Issue 3, 2010, Pages 1376-1386

  Oldak, Monika ^a,b   Maksym, Radoslaw B ^a,b   Sperling, Tanya ^c   Yaniv, Moshe ^d   Smola, Hans ^e   Pfister, Herbert J ^c   Malejczyk, Jacek ^b   Smola, Sigrun ^a,c  

^a SAARLAND UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c UNIVERSITY OF COLOGNE   (Germany)

^d INSTITUT PASTEUR   (France)

^e Paul Hartmann AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA4 INTEGRIN; CALCIUM; GLYCOPROTEIN E2; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR JUNB;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 8; KERATINOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; WART VIRUS;

BASE SEQUENCE; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DIMERIZATION; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN BETA4; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATORS;

HUMAN PAPILLOMAVIRUS TYPE 8; PAPILLOMAVIRIDAE;

EID: 73949122689     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01220-09     Document Type: Article

References (50)

1. Angel, P., A. Szabowski, and M. Schorpp-Kistner. 2001. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 20: 2413-2423.
2. Bakiri, L., K. Matsuo, M. Wisniewska, E. F. Wagner, and M. Yaniv. 2002. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 22:4952-4964.
3. Behren, A., C. Simon, R. M. Schwab, E. Loetzsch, S. Brodbeck, E. Huber, F. Stubenrauch, H. P. Zenner, and T. Iftner. 2005. Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway. Cancer Res. 65:11613-11621.
4. Blachon, S., and C. Demeret. 2003. The regulatory E2 proteins of human genital papillomaviruses are proapoptotic. Biochimie 85:813-819.
5. Boeckle, S., H. Pfister, and G. Steger. 2002. A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2. Virology 293:103-117.
6. Bohmann, D., T. J. Bos, A. Admon, T. Nishimura, P. K. Vogt, and R. Tjian. 1987. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 238:1386-1392.
7. Borradori, L., and A. Sonnenberg. 1999. Structure and function of hemidesmosomes: more than simple adhesion complexes. J. Investig. Dermatol. 112:411-418.
8. Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
9. Corbi, A. L., U. B. Jensen, and F. M. Watt. 2000. The alpha2 and alpha5 integrin genes: identification of transcription factors that regulate promoter activity in epidermal keratinocytes. FEBS Lett. 474:201-207.
10. Culp, T. D., L. R. Budgeon, M. P. Marinkovich, G. Meneguzzi, and N. D. Christensen. 2006. Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J. Virol. 80:8940-8950.
11. Day, P. M., R. B. Roden, D. R. Lowy, and J. T. Schiller. 1998. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 72:142-150.
12. Demeret, C., C. Desaintes, M. Yaniv, and F. Thierry. 1997. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol. 71:9343-9349.
13. Desaintes, C., C. Demeret, S. Goyat, M. Yaniv, and F. Thierry. 1997. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 16:504-514.
14. Dostatni, N., P. F. Lambert, R. Sousa, J. Ham, P. M. Howley, and M. Yaniv. 1991. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev. 5:1657-1671.
15. Dowhanick, J. J., A. A. McBride, and P. M. Howley. 1995. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69:7791-7799.
16. Efimova, T., P. LaCelle, J. F. Welter, and R. L. Eckert. 1998. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway. J. Biol. Chem. 273:24387-24395.
17. Fothergill, T., and N. A. McMillan. 2006. Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology 352:319-328.
18. Fuchs, E., J. Dowling, J. Segre, S. H. Lo, and Q. C. Yu. 1997. Integrators of epidermal growth and differentiation: distinct functions for beta 1 and beta 4 integrins. Curr. Opin. Genet. Dev. 7:672-682.
19. Goodwin, E. C., E. Yang, C. J. Lee, H. W. Lee, D. DiMaio, and E. S. Hwang. 2000. Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 97:10978-10983.
20. Grm, H. S., P. Massimi, N. Gammoh, and L. Banks. 2005. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein. Oncogene 24:5149-5164.
21. Hadaschik, D., K. Hinterkeuser, M. Oldak, H. J. Pfister, and S. Smola-Hess. 2003. The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J. Virol. 77:5253-5265.
22. Heino, P., J. Zhou, and P. F. Lambert. 2000. Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2. Virology 276:304-314.
23. Horner, S. M., and D. DiMaio. 2007. The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells. J. Virol. 81:6254-6264.
24. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2007. Human papillomaviruses. IARC Monogr. Eval. Carcinog. Risks Hum. 90:1-636.
25. Jang, S. I., N. Karaman-Jurukovska, M. I. Morasso, P. M. Steinert, and N. G. Markova. 2000. Complex interactions between epidermal POU domain and activator protein 1 transcription factors regulate the expression of the profilaggrin gene in normal human epidermal keratinocytes. J. Biol. Chem. 275:15295-15304.
26. Kruppel, U., A. Muller-Schiffmann, S. E. Baldus, S. Smola-Hess, and G. Steger. 2008. E2 and the coactivator p300 can cooperate in activation of the human papillomavirus type 16 early promoter. Virology 377:151-159.
27. Longworth, M. S., and L. A. Laimins. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68:362-372.
28. Lopez-Rodriguez, C., H. C. Kluin-Nelemans, and A. L. Corbi. 1996. AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene. J. Immunol. 156:3780-3787.
29. Massimi, P., D. Pim, C. Bertoli, V. Bouvard, and L. Banks. 1999. Interaction between the HPV-16 E2 transcriptional activator and p53. Oncogene 18: 7748-7754.
30. McMurray, H. R., D. Nguyen, T. F. Westbrook, and D. J. McAnce. 2001. Biology of human papillomaviruses. Int. J. Exp. Pathol. 82:15-33.
31. Muller, A., A. Ritzkowsky, and G. Steger. 2002. Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300. J. Virol. 76:11042-11053.
32. Murtagh, J., E. McArdle, E. Gilligan, L. Thornton, F. Furlong, and F. Martin. 2004. Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling. J. Cell Biol. 166:133-143.
33. Oldak, M., H. Smola, M. Aumailley, F. Rivero, H. Pfister, and S. Smola-Hess. 2004. The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. J. Virol. 78:10738-10746.
34. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U. S. A. 90:8392-8396.
35. Peng, Y. C., F. Kuo, D. E. Breiding, Y. F. Wang, C. P. Mansur, and E. J. Androphy. 2001. AMF1 (GPS2) modulates p53 transactivation. Mol. Cell. Biol. 21:5913-5924.
36. Pfister, H. 2003. Human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 2003:52-56.
37. Pillai, S., D. D. Bikle, M. L. Mancianti, P. Cline, and M. Hincenbergs. 1990. Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J. Cell Physiol. 143:294-302.
38. Psyrri, A., and D. DiMaio. 2008. Human papillomavirus in cervical and head-and-neck cancer. Nat. Clin. Pract. Oncol. 5:24-31.
39. Purdie, K. J., C. J. Sexton, C. M. Proby, M. T. Glover, A. T. Williams, J. N. Stables, and I. M. Leigh. 1993. Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res. 53:5328-5333.
40. Ramirez-Carrozzi, V., and T. Kerppola. 2003. Asymmetric recognition of nonconsensus AP-1 sites by Fos-Jun and Jun-Jun influences transcriptional cooperativity with NFAT1. Mol. Cell. Biol. 23:1737-1749.
41. Risse, G., K. Jooss, M. Neuberg, H. J. Bruller, and R. Muller. 1989. Asymmetrical recognition of the palindromic AP1 binding site (TRE) by Fos protein complexes. EMBO J. 8:3825-3832.
42. Rossi, A., S. I. Jang, R. Ceci, P. M. Steinert, and N. G. Markova. 1998. Effect of AP1 transcription factors on the regulation of transcription in normal human epidermal keratinocytes. J. Investig. Dermatol. 110:34-40.
43. Schmidt, H. M., G. Steger, and H. Pfister. 1997. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1. J. Virol. 71:8029-8034.
44. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
45. Soto, U., C. Denk, P. Finzer, K. J. Hutter, H. zur Hausen, and F. Rosl. 2000. Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition. Int. J. Cancer 86:811-817.
46. Stubenrauch, F., I. M. Leigh, and H. Pfister. 1996. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J. Virol. 70:119-126.
47. Takaoka, A. S., T. Yamada, M. Gotoh, Y. Kanai, K. Imai, and S. Hirohashi. 1998. Cloning and characterization of the human beta4-integrin gene promoter and enhancers. J. Biol. Chem. 273:33848-33855.
48. Tan, S. H., L. E. Leong, P. A. Walker, and H. U. Bernard. 1994. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68:6411-6420.
49. Wilhelmsen, K., S. H. Litjens, and A. Sonnenberg. 2006. Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. Mol. Cell. Biol. 26:2877-2886.
50. Zenz, R., and E. F. Wagner. 2006. Jun signaling in the epidermis: from developmental defects to psoriasis and skin tumors. Int. J. Biochem. Cell Biol. 38:1043-1049.